Cargando…
Antibody therapies for the prevention and treatment of viral infections
Antibodies are an important component in host immune responses to viral pathogens. Because of their unique maturation process, antibodies can evolve to be highly specific to viral antigens. Physicians and researchers have been relying on such high specificity in their quest to understand host–viral...
Autores principales: | Salazar, Georgina, Zhang, Ningyan, Fu, Tong-Ming, An, Zhiqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627241/ https://www.ncbi.nlm.nih.gov/pubmed/29263875 http://dx.doi.org/10.1038/s41541-017-0019-3 |
Ejemplares similares
-
Antibody therapies for the treatment of COVID-19
por: Ku, Zhiqiang, et al.
Publicado: (2020) -
T-cell receptor mimic (TCRm) antibody therapeutics against intracellular proteins
por: Xu, Yixiang, et al.
Publicado: (2019) -
Proteinase-nicked IgGs: an unanticipated target for tumor immunotherapy
por: Jordan, Robert E., et al.
Publicado: (2018) -
Engineering antibody and protein therapeutics to cross the blood–brain barrier
por: Zhao, Peng, et al.
Publicado: (2022) -
The 2018 Nobel Prize in Medicine for breakthroughs in targeting immune checkpoint inhibitors: a brief perspective
por: Rios, Adan, et al.
Publicado: (2019)